News

Researchers have presented a possible explanation for the diverse immune responses to SARS-CoV-2 and the available vaccines.

Plants used by the indigenous population in Australia, the Aboriginal people, may be able to help cancer patients who are no longer susceptible to treatment with chemotherapy.

Researchers have discovered a non-lethal way to study scorpion venom genes by triggering the emptying of the animal’s venom glands using electrostimulation. The study was published in PLOS ONE.

Scientists have reacted to a recent interview in which Pascal Soriot, the executive director and chief executive officer of AstraZeneca, commented on the ability of the AstraZeneca COVID-19 vaccine to induce long-lasting T-cell responses.

A test to measure both T-cell and antibody response to SARS-CoV-2 in a single blood sample has been developed by scientists at Cardiff University.

Researchers at Rutgers University have developed a novel approach for delivering DNA therapeutics that relies on suction.

The current standard for women receiving the human papillomavirus (HPV) vaccine is a three-dose regimen, however, a randomized controlled trial of 2,275 women in Kenya has shown that a single dose was highly effective.

Researchers have found that variants of the venom produced by the cone snail could offer future possibilities for developing new fast-acting drugs to help treat diabetes.

Researchers have developed a novel vaccine that in guinea pigs offers protection against infection by the bacterium that causes Lyme Disease and may also combat other tick-borne diseases.

A study has analyzed a quarter-century of national survey data to better understand how social, economic and geographical inequalities in India shaped the chances of children remaining unvaccinated between 1992 and 2016.